Prometrium Cost in Kentucky: 2026 Prices, Insurance, and Savings Options

How Much Does Prometrium Cost in Kentucky in 2026?
At a glance
- Brand Prometrium list price / ~$180 per month (Solvay/AbbVie)
- Average Kentucky cash-pay price / ~$45 per month at retail pharmacies
- Compounded micronized progesterone / ~$25 per month via 503A pharmacies
- Kentucky Medicaid coverage / Not covered
- Telehealth prescribing / Legal and available statewide in Kentucky
- Standard dosing / 200 mg oral capsule, once daily at bedtime
- Generic availability / Yes, micronized progesterone capsules
- Compounded legality in KY / Yes, through licensed 503A pharmacies
- Manufacturer savings card / Available from AbbVie for commercially insured patients
- Typical indication / Endometrial protection during menopausal hormone therapy
Kentucky Prometrium Pricing: Brand, Generic, and Compounded
The gap between sticker price and what Kentucky patients actually pay is wide. AbbVie's (formerly Solvay) brand-name Prometrium lists at approximately $180 per month for a standard 30-day supply of 200 mg capsules. That number rarely reflects what anyone hands over at the counter.
Generic micronized progesterone capsules, FDA-approved as therapeutically equivalent to Prometrium, have pushed retail cash-pay prices to an average of $45 per month across Kentucky pharmacies in 2026. Prices vary by pharmacy. A Kroger in Louisville may charge $38 while an independent in Pikeville lists $52. Calling two or three pharmacies before filling is worth the five minutes.
Compounded micronized progesterone from a Kentucky-licensed 503A compounding pharmacy costs roughly $25 per month. The 503A designation, defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, permits a licensed pharmacist to compound a medication for an individual patient with a valid prescription. This route is legal in Kentucky and offers the lowest per-month cost, though it requires a prescriber willing to write for a compounded formulation. Some physicians prefer FDA-approved products for consistency in potency and dissolution. The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) demonstrated that oral micronized progesterone at 200 mg per day effectively opposed estrogen-induced endometrial hyperplasia while producing a more favorable lipid profile than medroxyprogesterone acetate 1. That trial used the branded capsule formulation, and prescribers who cite PEPI data sometimes prefer the FDA-approved version for that reason.
Patients paying out of pocket should also check GoodRx, RxSaver, or the pharmacy's own discount program. These coupon aggregators frequently bring the generic price below $30 at chains like Walmart, Costco, and CVS locations throughout the Commonwealth.
Kentucky Medicaid and Prometrium Coverage
Kentucky Medicaid does not cover Prometrium. This applies to both the brand-name product and, in most cases, the generic micronized progesterone capsule under the current Kentucky Department for Medicaid Services formulary.
For the roughly 1.6 million Kentuckians enrolled in Medicaid managed care plans (WellCare, Anthem, Humana, Aetna, Molina, or United), the formulary exclusion means a prior authorization request is unlikely to succeed unless the prescriber documents medical necessity and failure of covered alternatives. Medroxyprogesterone acetate (Provera), a synthetic progestin, is typically the covered first-line option for endometrial protection on estrogen therapy.
The clinical distinction matters. The Endocrine Society's 2015 guidelines on menopausal hormone therapy note that micronized progesterone may carry a lower breast cancer risk than synthetic progestins based on observational data from the E3N French cohort study (N=80,377), which found that women using micronized progesterone with estradiol had no significant increase in breast cancer risk over a mean 8.1-year follow-up, while those using synthetic progestins did 2. Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the Women's Health Initiative hormone trials, has stated: "The type of progestogen matters. Micronized progesterone and certain newer progestins appear to have a better safety profile than medroxyprogesterone acetate for breast and cardiovascular outcomes."
If a Kentucky Medicaid patient's prescriber believes micronized progesterone is medically necessary (for example, in a patient with a history of adverse reactions to medroxyprogesterone acetate or with risk factors that favor natural progesterone), the prescriber can submit a prior authorization with supporting clinical documentation. Approval is not guaranteed. A second option for Medicaid enrollees is the compounded route at $25 per month, which may be cheaper than any copay alternative depending on the plan.
Commercial Insurance Coverage in Kentucky
Most commercial insurance plans available through Kynect (Kentucky's ACA marketplace), employer-sponsored plans, and federal employee plans cover generic micronized progesterone capsules at a Tier 1 or Tier 2 copay. Typical copays range from $5 to $25 per month depending on plan design.
Brand-name Prometrium coverage varies. Many commercial formularies place it on Tier 3 (preferred brand) or exclude it entirely with a "dispense as written" exception process. The practical advice: ask your pharmacist to fill with the generic unless your prescriber specifically requires the brand.
Anthem Blue Cross Blue Shield, the largest commercial insurer in Kentucky by enrollment, covers generic micronized progesterone on its standard formulary 3. Humana, headquartered in Louisville, similarly covers the generic on most plans. UnitedHealthcare and Cigna plans sold in Kentucky follow the same pattern. For patients on a high-deductible health plan (HDHP), the cash-pay or coupon price ($30 to $45) may be lower than the "insurance price" applied before the deductible is met. Always ask the pharmacist to run both the insurance and the cash/coupon price and take the lower one.
The AbbVie savings card (formerly Solvay) is available for commercially insured patients and can reduce out-of-pocket costs for brand Prometrium to as low as $25 per fill. The card is not valid for patients on government insurance (Medicaid, Medicare, Tricare, VA). Eligibility terms require a valid commercial prescription drug benefit and may cap annual savings. The card can be requested through the AbbVie website or through the prescriber's office.
Compounded Micronized Progesterone in Kentucky: Legality and Access
Compounding micronized progesterone is legal in Kentucky through 503A-licensed pharmacies. These pharmacies operate under the oversight of the Kentucky Board of Pharmacy and must compound pursuant to a patient-specific prescription from a licensed prescriber.
Kentucky has several 503A compounding pharmacies in Louisville, Lexington, Bowling Green, and other cities. Some also ship statewide. The typical compounded product is a micronized progesterone capsule in a base oil (often peanut oil or olive oil, matching the FDA-approved formulation), though compounding pharmacies can also prepare vaginal suppositories, sublingual troches, or topical creams at various strengths.
A few considerations for patients exploring this route. First, compounded products are not FDA-approved. They do not undergo the same bioequivalence testing as generic drugs. The FDA has raised concerns about potency variability in compounded hormone preparations, and a 2001 FDA survey found that 34% of compounded products tested failed one or more standard quality tests 4. Second, the cost savings are real. At $25 per month compared to $45 for generic or $180 for brand, the annual difference is $240 to $1,860.
Kentucky law does not restrict telehealth prescribing of compounded hormones. A physician, nurse practitioner, or physician assistant licensed in Kentucky can prescribe micronized progesterone (brand, generic, or compounded) via a telehealth visit, provided the encounter meets the Kentucky Board of Medical Licensure's standard of care requirements. This is particularly relevant for patients in rural Eastern Kentucky, where access to menopause specialists or compounding pharmacies may be limited.
How to Find the Lowest Prometrium Price in Kentucky
Price shopping is the single most effective strategy for reducing out-of-pocket costs on micronized progesterone in Kentucky. Here is a ranked approach.
Step 1: Check your insurance formulary. If generic micronized progesterone is covered at Tier 1, your copay ($5 to $15) is likely the best price. Call the number on the back of your insurance card or log in to the plan portal.
Step 2: Compare cash-pay prices. If you are uninsured, on Medicaid, or on a high-deductible plan, compare prices at three to five pharmacies. Use GoodRx or RxSaver to check prices at Kroger, Walmart, CVS, Walgreens, and Costco (Costco pharmacy is open to non-members in Kentucky). Walmart's $4/$10 generic program historically included some hormone formulations, though micronized progesterone availability on that list varies by location.
Step 3: Ask about compounding. If the $25 per month compounded price is appealing, ask your prescriber whether compounded micronized progesterone is appropriate for your clinical situation. Request a list of accredited 503A pharmacies in Kentucky. The Pharmacy Compounding Accreditation Board (PCAB) and the Kentucky Board of Pharmacy are both resources for verifying a pharmacy's licensure.
Step 4: Apply manufacturer coupons. The AbbVie savings card applies only to brand Prometrium and only for commercially insured patients. It will not help with the generic or compounded versions, and it excludes government insurance.
Step 5: Explore patient assistance programs. AbbVie offers a patient assistance program (PAP) for uninsured or underinsured patients who meet income eligibility criteria (typically at or below 200% of the federal poverty level). The program provides brand Prometrium at no cost. Application requires prescriber involvement and income verification.
Clinical Context: Why Prometrium Is Prescribed
Micronized progesterone is prescribed primarily for endometrial protection in postmenopausal women taking estrogen therapy. Without progesterone opposition, exogenous estrogen stimulates the endometrial lining and increases the risk of endometrial hyperplasia and cancer. The PEPI trial established that 200 mg of oral micronized progesterone taken for 12 days per cycle (or continuously) effectively prevents hyperplasia while preserving the HDL-cholesterol benefit of estrogen therapy 1.
Prometrium is also FDA-approved for the treatment of secondary amenorrhea (absent menstrual periods in premenopausal women). Off-label uses include luteal phase support in fertility treatment and progesterone supplementation in early pregnancy, though these uses involve different doses and routes of administration.
The standard dose for endometrial protection is 200 mg orally at bedtime. Bedtime dosing is recommended because micronized progesterone has a mild sedative effect mediated by its metabolite allopregnanolone, a positive allosteric modulator of the GABA-A receptor 5. This sedative property can actually benefit women with menopause-related sleep disturbances. A 2001 study in the Journal of Clinical Endocrinology and Metabolism reported improved sleep quality in postmenopausal women taking oral micronized progesterone, with increased non-REM sleep spindle frequency compared to placebo 5.
Prometrium capsules contain peanut oil. Patients with peanut allergies should not take the brand or generic capsule formulation and should instead use a compounded preparation in an alternative base oil, or consider vaginal progesterone products.
Telehealth Access for Prometrium in Kentucky
Kentucky permits telehealth prescribing of Prometrium and micronized progesterone statewide. Senate Bill 112 (2020) and subsequent legislation established a permanent telehealth framework in Kentucky that allows prescribers to evaluate patients, establish a provider-patient relationship, and prescribe medications, including controlled and non-controlled substances, via audio-video telehealth.
Micronized progesterone is not a controlled substance. It can be prescribed after a synchronous telehealth visit with a physician, APRN, or PA licensed in Kentucky. Several national telehealth platforms and HRT-focused clinics serve Kentucky patients, and HealthRX offers telehealth consultations for hormone therapy including micronized progesterone.
For patients in rural areas (Appalachian counties, the Jackson Purchase region, south-central Kentucky), telehealth eliminates the need to drive one to three hours to see a menopause specialist. The prescription can be sent electronically to any Kentucky pharmacy, including compounding pharmacies, or to a mail-order pharmacy.
Prometrium vs. Medroxyprogesterone Acetate: Cost and Clinical Differences
Kentucky Medicaid's preferred progestin, medroxyprogesterone acetate (MPA, brand Provera), costs approximately $4 to $10 per month as a generic. The price difference between MPA and generic micronized progesterone ($45) or compounded micronized progesterone ($25) is real.
The clinical difference is also real. The Women's Health Initiative (WHI) used conjugated equine estrogens plus MPA and found an increased risk of breast cancer (HR 1.26, 95% CI 1.00 to 1.59) after a mean 5.6 years of follow-up 6. The E3N French cohort study, which followed 80,377 postmenopausal women, found that estrogen combined with micronized progesterone did not significantly increase breast cancer risk (RR 1.00, 95% CI 0.83 to 1.22), while estrogen combined with synthetic progestins did (RR 1.69, 95% CI 1.50 to 1.91) 2.
The North American Menopause Society (NAMS) 2022 position statement acknowledges these data and notes that "micronized progesterone and dydrogesterone have not been associated with an increased risk of breast cancer" in observational studies, while cautioning that randomized trial data are limited 7. The decision between MPA and micronized progesterone should involve the prescriber and patient weighing cost, breast cancer risk profile, sleep effects, and tolerability. For a patient on Kentucky Medicaid who wants micronized progesterone, the $25 per month compounded option may be the most practical path.
Kentucky-Specific Pharmacy and Regulatory Notes
The Kentucky Board of Pharmacy regulates all 503A compounding pharmacies in the state. Patients can verify a pharmacy's license status through the Board's online portal. Kentucky does not currently require a separate compounding-specific license beyond the standard pharmacy permit, but compounding pharmacies must comply with USP 795 (nonsterile compounding) and USP 797 (sterile compounding) standards.
Kentucky is one of 15 states that has entered into a memorandum of understanding (MOU) with the FDA regarding interstate distribution of compounded medications. Under this MOU, 503A pharmacies that distribute more than 5% of their total prescription orders out of state must report this to the Kentucky Board of Pharmacy. For patients, this means Kentucky-licensed 503A pharmacies can legally ship compounded micronized progesterone to patients within Kentucky, and limited interstate distribution is permitted with reporting.
Prometrium 200 mg at bedtime, 30 capsules per month, filled as generic micronized progesterone at a Kentucky retail pharmacy with a GoodRx coupon: expect to pay $28 to $42 in May 2026.
Frequently asked questions
›How much does Prometrium cost in Kentucky?
›Does Kentucky Medicaid cover Prometrium?
›Is compounded micronized progesterone legal in Kentucky?
›Can I get Prometrium via telehealth in Kentucky?
›Which insurance plans cover Prometrium in Kentucky?
›What's the cheapest way to get Prometrium in Kentucky?
›Are there Kentucky Prometrium discount programs?
›How does the Solvay/AbbVie savings card work in Kentucky?
References
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208. PubMed
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. PubMed
- U.S. Food and Drug Administration. Prometrium (progesterone) capsules prescribing information. FDA
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. FDA
- Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R. Progesterone-induced changes in sleep in male subjects. Am J Physiol Endocrinol Metab. 1997;272(5):E885-E891. PubMed
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. PubMed
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. PubMed